News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Honoring the many lived experiences with Long COVID
RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.
Feature
34 Results
34 Results
RECOVER Research Update: June 2025
By studying millions of patients’ electronic health records (EHRs), RECOVER researchers are gaining understanding about who Long COVID affects, how it affects them, and why some people are more likely to be affected than others.
Research Update
RECOVER study provides new insights on the relationship between pregnancy and Long COVID
Recent RECOVER findings provide insights into how changes to the immune system during pregnancy may affect a woman’s risk of developing Long COVID.
Feature
RECOVER EHR study provides additional information about pediatric Long COVID symptoms
Researchers identified six common groups of symptoms experienced by children and adolescents with Long COVID.
Feature
R3 Seminar Recap: Understanding metformin use and Long COVID and ME/CFS following COVID-19 infection: Insights from two studies
A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection.
R3 Seminar Recap
RECOVER study highlights variations in Long COVID symptoms among children of different backgrounds
RECOVER researchers studied health records to understand how racial and ethnic backgrounds may impact pediatric Long COVID symptoms. These findings could support early detection and management of Long COVID symptoms for all children.
Feature
R3 Seminar Recap: Effectiveness of Paxlovid in Protecting Against Long COVID: EHR Insights
During the April 8th RECOVER Research Review (R3) Seminar, RECOVER researchers Hannah Mandel, MS, Fei Wang, PhD, Sandy Preiss, MS, and Abhishek Bhatia, MS presented findings from two different studies of electronic health records (EHRs). Rainu Kaushal, MD (Cornell University), Dr. Wang’s co-author, joined the presenters for the panel discussion and audience Q&A. Both studies examined whether taking the antiviral drug Paxlovid during a COVID-19 infection could help prevent Long COVID. Although Paxlovid is known to reduce the risk of severe COVID-19, there has been limited research into how Paxlovid might impact a person’s risk of developing Long COVID. The studies presented are two of the largest to date that have explored the role of Paxlovid in Long COVID prevention.
R3 Seminar Recap
RECOVER Representatives inform Long COVID research through authorship
Over the last two years, RECOVER Patient, Caregiver, and Community Representatives have helped plan and write more than 100 publications about RECOVER’s Long COVID research and its findings.
Feature
Reviewing RECOVER’s impact in 2024
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Feature